Resources

Past Presentation

Medications for Opioid Use Disorder: Who Should Get What When? | January 16, 2020

Date of Presentation: January 16, 2020

Type: Past Presentation  

Audience: Clinical  

Program: Substance Use Disorder  

Keywords: #buprenorphine  #methadone  #naltrexone  #opioid substitution therapy  #opioids  #OUD  

Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, compares methadone, buprenorphine, and extended release naltrexone in terms of efficacy on a stable dose, induction, retention, and systems-level constraints.

Presented by:

Dr. Jessica Gregg

Jessica Gregg, MD, PHD, is an Associate Professor of Medicine at Oregon Health and Science University. She received her undergraduate degree from Stanford University, her medical degree from the University of New Mexico, and her doctorate in medical anthropology from Emory University. She is board certified in internal medicine and addiction medicine. At OHSU, Dr. Gregg serves as the Director of the university’s addiction medicine ECHO clinics, as Associate Program Director for OHSU’s addiction medicine fellowship, and as Medical Director of the OHSU HRBR clinic, which provides low-barrier MAT to vulnerable adults. She also provides clinical care on IMPACT, OHSU’s inpatient addiction medical consult service.

Resources Provided:

Date added: January 16, 2020